Sponsor Pipeline

LAPIX Therapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06628206 Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis Rheumatoid Arthritis (RA) Recruiting
NCT06982352 Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis Atopic Dermatitis (AD) Recruiting
Disease Areas
Rheumatoid Arthritis (1) Psoriatic Arthritis (1) Psoriasis (1) Atopic Dermatitis (1)
Get alerts when LAPIX Therapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free